John Patrick Darby, the executive vice president and general counsel of Encompass Health Corporation, sold 8,906 shares of company stock [1].
Insider trading activity often serves as a barometer for investor confidence. This specific sale follows a recent increase in Medicare reimbursement rates for the Nashville-based company's services, leading some analysts to question the timing of the divestment.
According to an SEC Form 4 filing dated Aug. 10, 2026, the transaction reduced Darby's direct equity holdings by approximately 11% [1], [2]. Encompass Health, which trades on the NYSE under the ticker EHC, provides post-acute healthcare services across the U.S.
Market analysts said the sale occurred after the company benefited from the adjusted Medicare rates. While executives sell shares for various personal reasons, the timing relative to positive regulatory news can signal a shift in insider sentiment regarding the stock's current valuation [2].
Darby is one of three insiders who have recently sold shares within the organization [2]. The company is headquartered in Nashville, Tennessee, where it manages a network of rehabilitative hospitals.
Public filings do not specify the exact price per share for the 8,906 shares sold [1]. However, the reduction of a double-digit percentage of a personal holding is a notable move for a top executive in the legal and operational leadership of the firm.
“John Patrick Darby sold 8,906 shares of Encompass Health common stock.”
When high-ranking executives sell a significant portion of their holdings shortly after positive news—such as a Medicare rate hike—it may suggest they believe the stock has reached a short-term price ceiling. While not an explicit forecast of a decline, the 11% reduction in equity by the general counsel provides a data point for investors monitoring whether leadership believes the company is currently overvalued.
